What is NVAX's P/E ratio?

Novavax Inc (NVAX) currently trades at a P/E ratio of 9.82.

Novavax Inc reports a Return on Equity (ROE) of 60.68%.

What is NVAX's dividend yield?

Novavax Inc offers a dividend yield of 0.00%.

What is NVAX's Quality Score?

Our AI rates NVAX's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NVAX?

Our AI Timing Score for NVAX is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does NVAX belong to?

Novavax Inc is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Novavax Inc (NVAX) Stock Price, Quality Score & AI Analysis

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

NVAX AI Analysis Summary

Our AI summary for NVAX: Novavax Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 9.82, ROE of 60.68%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

NVAX

Novavax Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 7.66

0.25 (3.37%) Day Change

Watchlist Portfolio Compare Chart

9.82

P/E

-2.03

D/E

60.7%

ROE

-8.4%

ROA

0.00%

Div Yield

-0.07

PEG

NOVAVAX INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 7.66 Price 0.25 (3.37%) Day Change	NEWS SCORE: 99

NVAX, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

50%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	135
Magic Formula Rank by ROE	135
Magic Formula Rank by ROIC	149
Price	7.66
PBV / Sector	-8.42 / 44,022.72
Earning Per Share	-0.55

PE / Sector	9.82 / 19.17 GREAT
PEG or PE/Growth / Sector	-0.07 / 1.24
Average 1M Daily Value	24.25 M GREAT
Average 1W Daily Value	21.04 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-14.73 / 98.24
NPM Average (%) / Sector	-28.43 / -1,697.63
NPM Change Average (%) / Sector	-78.51 / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-8.42 / 185,260.96
ROA Average (%) / Sector	-8.49 / 36,684.70
ROA Change Average (%) / Sector	-147.56 / 422,221.66
ROE (%) / Sector	60.68 / 243,762.23 GREAT
ROE Average (%) / Sector	-14.83 / 48,758.47
ROE Change Average (%) / Sector	-362.88 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 08:00:37
Symbol	NVAX
Name	NOVAVAX INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	164.44 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,218.49 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 21 Firstfield Road, Gaithersburg, MD, United States, 20878

Phone: 240 268 2000

Website: https://www.novavax.com

Employees: 749

Sector: Healthcare >> Biotechnology

Description: Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.